Your browser doesn't support javascript.
loading
Potent Plasmodium falciparum gametocytocidal compounds identified by exploring the kinase inhibitor chemical space for dual active antimalarials.
van der Watt, Mariëtte E; Reader, Janette; Churchyard, Alisje; Nondaba, Sindisiwe H; Lauterbach, Sonja B; Niemand, Jandeli; Abayomi, Sijuade; van Biljon, Riëtte A; Connacher, Jessica I; van Wyk, Roelof D J; Le Manach, Claire; Paquet, Tanya; González Cabrera, Diego; Brunschwig, Christel; Theron, Anjo; Lozano-Arias, Sonia; Rodrigues, Janneth F I; Herreros, Esperanza; Leroy, Didier; Duffy, James; Street, Leslie J; Chibale, Kelly; Mancama, Dalu; Coetzer, Theresa L; Birkholtz, Lyn-Marie.
Afiliação
  • van der Watt ME; Department of Biochemistry, Institute for Sustainable Malaria Control and South African Medical Research Council Collaborating Centre for Malaria Research, University of Pretoria, Private Bag x20, Hatfield, Pretoria 0028, South Africa.
  • Reader J; Department of Biochemistry, Institute for Sustainable Malaria Control and South African Medical Research Council Collaborating Centre for Malaria Research, University of Pretoria, Private Bag x20, Hatfield, Pretoria 0028, South Africa.
  • Churchyard A; Plasmodium Molecular Research Unit, Wits Research Institute for Malaria, Department of Molecular Medicine and Haematology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand and National Health Laboratory Service, Johannesburg 2193, South Africa.
  • Nondaba SH; Department of Biochemistry, Institute for Sustainable Malaria Control and South African Medical Research Council Collaborating Centre for Malaria Research, University of Pretoria, Private Bag x20, Hatfield, Pretoria 0028, South Africa.
  • Lauterbach SB; Plasmodium Molecular Research Unit, Wits Research Institute for Malaria, Department of Molecular Medicine and Haematology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand and National Health Laboratory Service, Johannesburg 2193, South Africa.
  • Niemand J; Department of Biochemistry, Institute for Sustainable Malaria Control and South African Medical Research Council Collaborating Centre for Malaria Research, University of Pretoria, Private Bag x20, Hatfield, Pretoria 0028, South Africa.
  • Abayomi S; Department of Biochemistry, Institute for Sustainable Malaria Control and South African Medical Research Council Collaborating Centre for Malaria Research, University of Pretoria, Private Bag x20, Hatfield, Pretoria 0028, South Africa.
  • van Biljon RA; Department of Biochemistry, Institute for Sustainable Malaria Control and South African Medical Research Council Collaborating Centre for Malaria Research, University of Pretoria, Private Bag x20, Hatfield, Pretoria 0028, South Africa.
  • Connacher JI; Department of Biochemistry, Institute for Sustainable Malaria Control and South African Medical Research Council Collaborating Centre for Malaria Research, University of Pretoria, Private Bag x20, Hatfield, Pretoria 0028, South Africa.
  • van Wyk RDJ; Department of Biochemistry, Institute for Sustainable Malaria Control and South African Medical Research Council Collaborating Centre for Malaria Research, University of Pretoria, Private Bag x20, Hatfield, Pretoria 0028, South Africa.
  • Le Manach C; Drug Discovery and Development Centre (H3D), Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa.
  • Paquet T; Drug Discovery and Development Centre (H3D), Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa.
  • González Cabrera D; Drug Discovery and Development Centre (H3D), Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa.
  • Brunschwig C; Drug Discovery and Development Centre (H3D), Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa.
  • Theron A; Biosciences, Council for Scientific and Industrial Research, PO Box 395, Pretoria 0001, South Africa.
  • Lozano-Arias S; GlaxoSmithKline, Tres Cantos Medicines Development Campus, Severo Ochoa, 2, 28760 Tres Cantos, Madrid, Spain.
  • Rodrigues JFI; GlaxoSmithKline, Tres Cantos Medicines Development Campus, Severo Ochoa, 2, 28760 Tres Cantos, Madrid, Spain.
  • Herreros E; GlaxoSmithKline, Tres Cantos Medicines Development Campus, Severo Ochoa, 2, 28760 Tres Cantos, Madrid, Spain.
  • Leroy D; Medicines for Malaria Venture, International Center Cointrin, Route de Pré-Bois 20, 1215, Geneva, Switzerland.
  • Duffy J; Medicines for Malaria Venture, International Center Cointrin, Route de Pré-Bois 20, 1215, Geneva, Switzerland.
  • Street LJ; Drug Discovery and Development Centre (H3D), Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa.
  • Chibale K; Drug Discovery and Development Centre (H3D), Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa.
  • Mancama D; South African Medical Research Council, Drug Discovery and Development Research Unit, Department of Chemistry and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Rondebosch 7701, South Africa.
  • Coetzer TL; Biosciences, Council for Scientific and Industrial Research, PO Box 395, Pretoria 0001, South Africa.
  • Birkholtz LM; Plasmodium Molecular Research Unit, Wits Research Institute for Malaria, Department of Molecular Medicine and Haematology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand and National Health Laboratory Service, Johannesburg 2193, South Africa.
J Antimicrob Chemother ; 73(5): 1279-1290, 2018 05 01.
Article em En | MEDLINE | ID: mdl-29420756

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosfotransferases / Plasmodium falciparum / Inibidores de Proteínas Quinases / Aminopiridinas / Antimaláricos Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosfotransferases / Plasmodium falciparum / Inibidores de Proteínas Quinases / Aminopiridinas / Antimaláricos Idioma: En Ano de publicação: 2018 Tipo de documento: Article